POPDC1 and cancer: Suppression of POPDC1 or POPDC3 expression correlates strongly with disease progression and poor clinical prognosis in different cancer forms including gastric cancer [71], [72], lung cancer [73], hepatocellular carcinoma [74], breast cancer [75] and colorectal cancer [76].